Providence Capital Advisors, LLC Abb Vie Inc. Transaction History

Providence Capital Advisors, LLC

$487 Million
Q3 2024

A detailed history of Providence Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 16,219 shares of ABBV stock, worth $2.83 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

16,219

Previous 16,101 0.73%

Holding current value

$2.83 Million

Previous $2.76 Million 15.97%

% of portfolio

0.66%

Previous 0.62%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $19,333 - $23,520	118 Added 0.73%	16,219 $3.2 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $26,159 - $30,548	169 Added 1.06%	16,101 $2.76 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $48,745 - $55,540	-305 Reduced 1.88%	15,932 $2.9 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $14,160 - $16,392	106 Added 0.66%	16,237 $2.42 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $48,366 - $60,188	365 Added 2.32%	16,131 $2.17 Million
Q1 2023 May 17, 2023	BUY	$144.61 - $166.54 $350 Million - $403 Million	2,418,147 Added 2557.1%	2,512,713 $400 Million
Q1 2023 May 17, 2023	SELL	$144.61 - $166.54 $361 Million - $416 Million	-2,496,947 Reduced 99.37%	15,766 $2.51 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $11.5 Million - $13.2 Million	79,376 Added 522.55%	94,566 $15.1 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $1,244 - $1,492	9 Added 0.06%	15,190 $2.46 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $40,531 - $46,486	302 Added 2.03%	15,181 $2.04 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $735,991 - $935,686	-5,348 Reduced 26.44%	14,879 $2.28 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $403,462 - $500,583	-3,057 Reduced 13.13%	20,227 $3.28 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $106,892 - $135,250	995 Added 4.46%	23,284 $3.15 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $752,780 - $854,518	7,075 Added 46.5%	22,289 $2.4 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $84,168 - $93,768	800 Added 5.55%	15,214 $1.71 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $70,484 - $77,595	689 Added 5.02%	14,414 $1.56 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $123,310 - $166,482	1,532 Added 12.56%	13,725 $1.47 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $43,728 - $51,322	509 Added 4.36%	12,193 $1.07 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $857,255 - $1.15 Million	11,684 New	11,684 $1.15 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $7,482 - $11,343	-116 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $8,367 - $10,469	116 New	116 $10,000
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $13,801 - $18,481	-150 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $13,434 - $14,731	150	150 $15,000

Others Institutions Holding ABBV

# of Institutions

3,850

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $308B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Abb Vie Inc. Transaction History